Safety and Efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the Treatment of Pancreatic Lesions: A Pancardinal-4 Prospective Registry
Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY
This is a 7-year prospective single-center registry study to assess the safety and efficacy of Endoscopic Ultrasound (EUS) Guided Radiofrequency Ablation (RFA) in the treatment of pancreatic lesions.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
View:
• Diagnosis of any pancreatic pre-malignant lesion and/or pancreatic malignancy
• Patients already undergoing EUS-RFA for treatment of pancreatic lesions clinically
Locations
United States
Texas
The University of Texas Health Science Center at Houston
RECRUITING
Houston
Contact Information
Primary
Amatullah Alibhai, MBA
Amatullah.Alibhai@uth.tmc.edu
713-500-6658
Backup
Nicole Fatheree, BBA
Nicole.Fatheree@uth.tmc.edu
713-500-5669
Time Frame
Start Date: 2026-04-07
Estimated Completion Date: 2033-04-01
Participants
Target number of participants: 60
Treatments
Adult patients who undergo EUS-RFA for treatment of pancreatic lesions
Related Therapeutic Areas
Sponsors
Leads: The University of Texas Health Science Center, Houston